FIELD: medicine, experimental hematology.
SUBSTANCE: the present innovation deals with modeling hemolytic anemia due to simultaneous intraperitoneal injection of exogenous factor for laboratory animals. One should introduce high-molecular polyethylenoxide at 3-6·106 molecular weight at the dosages of 0.6-1.5 mg/kg. The method enables to model hemolytic anemia due to applying high-molecular polyethylenoxide (HMPEO).
EFFECT: higher efficiency of modeling.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING ACQUIRED TOXIC HAEMOLYTIC ANAEMIA EXPERIMENTALLY | 2013 |
|
RU2528976C1 |
| METHOD OF TREATING ANAEMIA, ASSOCIATED WITH FAILURE OF PORPHYRINS SYNTHESIS | 2010 |
|
RU2435574C1 |
| METHOD FOR CORRECTION OF ANEMIA IN ERYTHROCYTES TRANSFUSION DEPENDENT PATIENTS WITH BETA-THALASSEMIA | 2023 |
|
RU2820878C1 |
| TETRAKIS-(L-HISTIDINATO)-μ-PEROXYDICOBALT)III HEPTAHYDRATE HAVING ANTIANEMIC, RADIOPROTECTIVE AND ANTIARRHYTHMIC ACTIVITIES | 1999 |
|
RU2151773C1 |
| HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
| METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
| PLASMA SUBSTITUTE SOLUTION WITH HEMOCORRECTING AND IMMUNOMODULATING PROPERTIES | 1998 |
|
RU2166944C2 |
| AGENT ELICITING ANTIANEMIC AND IMMUNOMODULATING ACTIVITY | 2001 |
|
RU2208440C2 |
| METHOD OF TREATMENT OF PATIENT WITH CHRONIC ASIDEROTIC ANEMIA IN UTERUS BLEEDING | 1998 |
|
RU2148409C1 |
| METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
